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Glia is a class of cells that with neurons are the basic cells of the central nervous 
system (CNS). The main difference between glia and neurons lies in their electrical 
excitability; neurons are electrical excitable cells whereas glia represents non-
excitable neural cells. Glia is consisted by the macroglia astrocytes, 
oligodendrocytes, chondroitin sulfate proteoglycan NG-2 positive cells and 
microglia (Freeman, 2010). Astrocytes are the most abundant cell type in the 
human brain but their function has been extensively studied only over the last 
decades. 
Founders of glial research 
The idea of the co-existence of excitable and non-excitable elements in the brain 
was first promulgated in 1836 by the Swiss professor of anatomy and physiology 
Gabriel Gustav Valentin (1810-1883). The concept ‘glia’ was coined in 1858 by 
Rudolf Karl Virchow (1821-1902) who was one of the most influential 
pathologists of the 19th century. Virchow derived the term ‘glia’ from the Greek 
‘γλία’ for something slimy and of sticky appearance. He initially defined glia as a 
‘connective substance’ which forms in the brain and in the spinal cord. For 
Virchow, glia was a connective tissue, completely devoid of any cellular elements. 
The first image of neuroglial cell was obtained by Heinrich Muller in 1851 and in 
1869 Jakob Henle published the first image of cellular networks formed by stellate 
cells (astrocytes) (Verkhratsky and Butt, 2007). 
Camillo Golgi (1843) using microscopic techniques discovered a huge diversity of 
glial cells in the brain and found the contacts between glial cells and blood vessels. 
In 1893 Michael von Lenhossek proposed the term astrocyte (from the Greek for 
star, astro, and cell, cyte). At the end of 19th century several possible functions for 
glial cells were consedered but until the 1980 glial cells were still regarded as 
passive elements of the CNS, bearing mostly supportive and nutritional roles 
(Golgi, 1903). 
The first breakthrough discovery for astrocytes was made in 1984 when groups led 
by Helmut Kettenmann and Harold Kimelberg discovered glutamate and GABA 
receptors. Several years later, in 1990, Ann Cornell-Bell and Steve Finkbeiner 
found that astroglial cells are capable of long-distance communication by means of 
propagating calcium waves. Detailed analysis during the last two decades 
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demonstrated that astrocytes are capable of expressing practically every type of 
neurotransmitter receptor (Kettenman, 1984). 
Phylogeny of glia 
Glia appear early in phylogeny, even primitive nervous systems of invertebrates 
such as annelids and leeches, crustacea and insects, and molluscs and cephalopods 
contain clearly identifiable glial cells, and their study has provided a significant 
contribution to our understanding of glial cell physiology. Most strikingly, 
however, the evolution of the CNS is associated with a remarkable increase in the 
number and complexity of glial cells (Fig. 1A). In the leech, for example, the 
nervous system is organized in ganglia; each ganglion contains 20-30 neurons, 
which are coupled to one giant glial cell. The nervous system of the nematode 
Cianorhabditis elegans contains 302 neurons and only 56 glial cells. In drosophila, 
glial cells already account for ~20-25 per cent of cels in the nervous system, and in 
rodents about 60 per cent of all neural cells are glia (Oberheim, 2006). 
In human brain, glial cells are certainly the most numerous as it is generally 
believed that glial cells are outnumber neurons in human brain by a factor of 10 to 
50, although the precise number of cells in the brain of Homo sapiens remains 
unknown. Early estimates put a total number of neurons at ~85 billion, however, 
now we know that this number should be substantially larger as a cerebellum alone 
contains ~105 billion neurons. Therefore, the human brain as a whole may contain 
several hundred billion of neurons and probably several trillions of astrocytes. 
Morphological data for the cortex are more reliable and they show that human 
brain has the highest ratio among all species (0.3:1 in mice and about 1.65:1 in 
human brain) (Fig. 1B). Interestingly, however, the overall volume of the glial 
compartment remains more or less constant as they occupy about 50 per cent of the 
nervous system throughout the evolutionary ladder (Oberheim, 2006). 
Not only does the human brain have the largest number of glia, but the glia cells in 
primates also show remarkable differences compared to non-primates. The most 
abundant astroglial cells type in human and primate brain are the protoplasmic 
astrocytes, which densely populate cortex and hippocampus. Human protoplasmic 
astrocytes are much larger and far more complex than protoplasmic astrocytes in 
rodent brain. The linear dimensions of human protoplasmic astroglial cells are 
about 2.75 times larger and have a volume about 27 times greater than the same 
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cells in mouse brain (Fig 1C, D). Furthermore, human protoplasmic astrocytes 
have about 40 main processes and these processes have immensely more complex 
branching than mouse astrocytes. As a result, every human protoplasmic astrocyte 
contacts and enwraps two million synapses compared to only 90.000 synapses 
covered by the processes of a mouse astrocyte (Oberheim, 2006). 
Moreover the brain of primates contains specific astroglial cells, which are absent 
in other vertebrates. Most notable of these are the interlaminar astrocytes, which 
reside in layer I of the cortex, this layer is densely populated by synapses but 
almost completely devoid of neuronal cell bodies. These interlaminar astrocytes 
have a small cell body, several short and one or two very long processes which can 
be up to 1 mm long. Human brains also contain polarized astrocytes, which are 
uni- or bipolar cells which dwell in layers V and VI of the cortex quite near to 
white matter and they have one or two very long (up to 1 mm) processes 
(Colombo, 2004). 
Most interestingly, the evolution of neurons produced fewer changes in their 
appearance. The shape and the dimensions of neurons have not changed 
dramatically over the phylogenetic ladder (Fig 1C). Thus, at least morphologically, 
evolution resulted in far greater changes in glia than in neurons, which most likely 
has important, although yet undetermined, significance (Oberheim, 2006) 
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Figure 1: Phylogenetical advance of glial cells. (A) percentage of glial cells is increased in 
phylogenesis (B) the numbers of glia and neurons in cortex is more precisely quantified, and this 
graph ahows the glia/neuron ratio in cortex of high primates (C) graphic representation of 
neurons and astroglia in mouse and in human cortex (D) relative increase in glial dimensions 
and complexity during evolution. (Modified from: Verkhratsky and Butt, 2007) 
 
Astroglial morphogenesis and heterogeneity 
All neural cells derive from the neuroepithelium, which forms the neural tube. 
These cells are pluripotent in a sense that their progeny may differentiate into 
neurons or macroglial cells with equal probability, and therefore the 
neuroepithelial cells may be defined as true neural progenitors. These neural 
progenitors give rise to neuronal or glial cells, neuroblasts and glioblasts 
respectively, which in turn differentiate into neurons or macroglial cells. For many 
years it was believed that the neuroblasts and glioblasts appear very early in 
development and that they form two distinct and non-interchangeable pools 
committed, respectively, to produce strictly glial lineages. It was also taken for 
granted that the pool of precursors cells is fully depleted around birth, and 
neurogenesis is totally absent in the mature brain. Recently, however, this 
paradigm has been challenged, as it appears that neuronal and glial lineages are 
much more more closely related than was previously thought, and that the mature 
brain still has numerous stem cells, which may provide for neuronal replacement. 
Moreover, it turns out that neural stem cells have many properties of astroglia 
(Goldman, 2003). 
The modern scheme of neural cell development is as follows: At the origin of all 
neural cell lineages lie neural progenitors in the form of neuroepithelial cells. 
Morphologically, neural progenitors appear as elongated cells extending between 
the two surfaces of the neuronal tube. Very early in development, the neuronal 
progenitors give rise to radial glial cells, which are in fact the first cells that can be 
distinguished from neuroepithelial cells. These radial glial cells are the central 
element in the subsequent neurogenesis, because they act as the main neural 
progenitors during development, giving rise to neurons, astrocytes and some 
oligodendrocytes. Astrocytes are generated both from radial glia and later in 
development from glial precursors that also give rise to oligodendrocytes. 
Moreover, the radial glia cells and astrocytes that differentiate from then retain the 
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function of stem cells in the brain throughout maturation and adulthood (Fig. 2) 
(Verkhratsky and Butt, 2007). 
 
 
Figure 2: Modern views on pathways of neural cell development. (From: Verkhratsky and Butt, 
2007) 
 
Astrocytes are characterized by functional and morphological heterogeneity. 
Astroglial precursors are programmed differentially according to the brain region 
and the developmental stage and they give rise to diverse subtypes of astrocytes 
(Fig. 3) (Verkhratsky and Butt, 2007).  Morphologically, the name astroglial cell is 
an umbrella term that covers several types of glial cell. The largest group are the 
‘true’ astrocytes, which have the classical stellate morphology and comprise 
protoplasmic astrocytes and fibrous astrocytes of the grey and white matter, 
respectively (Fig 3 IV). The second big group of astroglial cells is the radial glia, 
which are bipolar cells with an ovoid cell body and elongated processes (Fig 3 II). 
In addition to the two major groups of astroglial cells, there are smaller populations 
of specialized astroglia localized to specific regions of the CNS, namely the velate 
astrocytes of the cerebellum, the interlaminar astrocytes of the primate cortex, 
tanycytes, pituicytes in the neurohypophysis and perivascular and marginal 
astrocytes. Finally, brain astroglia also include several types of cells that line the 
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ventricles or the subretinal space, namely ependymocytes, choroid plexus cells and 
retinal pigment epithelial cells. 
                             
Figure 3: Morphological types of astrocytes. Ia-pial tanycyte, Ib-vascular tanycyte, II-radial 
astrocyte (Bergmann glial cell), III-marginal astrocyte, IV-protoplasmic astrocyte,V-velate 
astrocyte,VI-fibrous astrocyte, VII-perivascular astrocyte, VIII-interlaminar astrocyte, IX-
immature astrocyte, X-ependymocyte, XI-choroid plexus cell. (From: Rechenbach A. and 
Wolburg H., 2005) 
The lack of reliable astrocyte specific markers for distinguishing specific 
developmental stages and specific subtypes of astrocytes complicates their study. 
However, there are some basic criteria for astrocytes that are common ammong 
literature. First of all astrocytes are not excitable like neurons, they have a negative 
membrane potential, they express the Glial Acidic Fibrillary Protein (GFAP) and 
glutamate transportes, they contain glycogen granules and they communicate with 
adjecant astrocytes through gap junctions. Additionally, astrocytes processes are in 
contact with the blood vessels and the synapses (Kimelberg, 2010). 
Astrocyte function in the CNS 
Astrocytes cover a wide range of functions and therefore they are very important 
for the proper development and function of the brain. Astroglial cells form 
pathways for the migration of newborn neurons and control the formation of the 
synapses during development (Raponi et al., 2007). Astrocytes retain their 
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multipotency and give rise to new neurons and glial cells during adulthood (Raponi 
et al., 2007; Verkhratsky and Butt 2007). Moreover, they support the structure of 
the brain and they are the main cells that maintain the blood-brain barrier (Nag, 
2011). Astrocytic processes sorround the synapses and absorb the excess of 
glutamate, that preventing glutamate induced neurotoxicity (Krencik et al, 2011 ). 
At the same time they provide metabolic substrates to neurons (Rouach et al, 2008; 
Verkhratsky and Butt, 2007). Astrocytes can also release a variety of 
gliotransmitters such as 5’-triphosphate, glutamate and D-serine, and control 
sunaptic plasticity (Zhang and Haydon, 2005 ). Finally, astrocytes control the ion-
distribution, the pH and the water homeostasis through ion-channels and specific 
aquaporins (Verkhratsky and Butt, 2007). 
In detail, neurogenesis in adult humans is restricted to the hippocampus and 
subventricular zone. In both locations, the stem elements that produce neurons are 
astroglia. These ‘stem’ astrocytes have the morphology, physiology and 
biochemical markers characteristic for astrocytes: they express GFAP, have 
negative resting membrane potentials and they are non-excitable. ‘stem’ astrocytes 
different from mature astrocytes by specific expression of the protein nestin and 
some of them form cilia. Neurons born in the subventricular zone migrate to the 
olfactory bulb, whereas those produced in the hippocampus remain there and 
integrate themselves into existing neuronal networks. ‘stem’ astrocytes residing in 
the hippocampus and subventricular zone are multipotent, as they give birth to both 
neurons and glia (Mori et al,  2005). 
In contrast to neurogenesis, gliogenesis occurs everywhere. New glial cells are 
born locally and the locality also mainly determines the type of glial cell produced, 
as it was reffered previously. In the subcortical white matter most of the newly 
produced glial cells are oligodendrocytes, whereas in the spinal cord astrocytes and 
oligodendrocytes are produced roughly in the same quantities (Mori et al, 2005). 
The first neural cells to develop are radial glia. After this, neural precursors in the 
ventricular zone (VZ) and subventricular zone  (SVZ) immediately surrounding the 
lumen of the neural tube migrate to their final destinations and give rise to the 
enormously diverse range of neurons and glia found in the adult brain. An 
important function of foetal glial cells is to provide the scaffolding along which 
neural precursosrs migrate. Not all neurons migrate along radial glia, buta is 
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always the case where neurons are organized in layers such as the cerebellum, 
hippocampus, cerebral cortex and spinal cord. After neurons reach their final sites, 
they extend axons, which in some cases grow for considerable distances and have 
to cross the brain middline to reach their synaptic targets. Channels formed by 
astrocytes provide a mechanical and guidance substrate for axon growth. In the 
corpus callosum, for example, astrocytes form a bridge that connects the left and 
the right sides of the telencephalon. The ability of astrocytes to support axon 
growth decreases with age, embryonic astrocytes strongly sypport axon growth, 
whereas mature astrocytes inhibit axon growth (Alvarez-Buylla et al, 2001). 
Protoplasmic astrocytes in the grey matter are organized in a very particular way, 
with each astrocyte controlling its own three-dimensional anatomical territory. 
Individual astrocytes establish contacts with blood vessels, neurons and synapses 
residing within their anatomical domain. Using clearly delineated anatomical 
territories, astrocytes divide the whole of grey matter into seperate domains, the 
elements of which are integrated via the processes of protoplasmic astrocytes. The 
astrocytic processes provide for local sigmalling within the domain as their 
membranes that contact neurons, synapses and blood vessels are packed with 
receptor, which sense the ongoing activity (Allen and Barres, 2005). 
Astrocytes are not very much involved in the blood-brain barrier function per se, 
but astrocytes are important in the regulation of the bloo-brain interface as a whole. 
Astrocyte endfeet membranes are enriched with numerus receptors, transporters 
and channels which mediate glial-endothelial communication and regulate 
exchange through the glial-vascular interface. It appears that all astrocytes 
participate in the glial-vascular interface, through which the astrocytes maintains 
the exchange between blood and its own territory, thus establishing metabolically 
indepedent glia-neurone-vascular units. Astrocytes also play a central role in 
regulation of the local vascular tone, hence linking the metabolic demands of grey 
matter with local blood supply (Verkhratsky and Butt, 2007). 
The notion that astroglial cells provide a metabolic connection between neurons 
and blood vessels was initially made by Camillo Golgi in the 1870s. Recent 
advances in in situ cellular imaging have clearly demonstrated that astroglial Ca2+ 
signals triggered by neuronal activity enter endfeet and initiate the release of 
vasoactive aubstances, which in turn affect the tone of small artelioles enwrapped 
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by these endffet. In fact, astrocytes are able to provide dual control over the 
neighbouring blood vessel: they may euther induce vasolidation or 
vasoconstriction.  
Maintenance of the extracellular ion composition is of paramount importance for 
brain function, because every shift in ion concetration profoundly affects the 
membrane properties of nerve cells and hence thei ecitability. Apart from 
preserving their own transmembrane ion homeostasis, astroglial cells are heavily 
involved in maintenance of extracellular ion concetrations. As neuronal activity 
inevitably associated with influx of Na+ and Ca2+ and efflux of K+ the extracellulae 
concetration of these ions vary.  Astrocytes help prevent the accumulation of 
extracellular K+, thereby stabilizon neuronal activity (Kofuji and Newman, 2004). 
Astrocytes regulate water exchange between blood and brain and within the brain 
compartments through nomerous aquaporins, the latter being particularly 
concetrated in the endfeet enwrapping blood vessels. On a systemic level, water 
homeostasis in the brain is controlled by several neuropeptides produced and 
released by neurosecretory cells (Simard and Nedergaard, 2004). 
The brain produces energy by oxidizing glucose. The brain receives glucose and 
O2 from the blood supply. Neurones account for about 90 per cent of brain energy 
consumption, and glia cells are responseble for the remaining 10 per cent. Neurons 
require a continuous supply of energy to fuel their Na+-K+ ATPases, which are 
constantly active to maintain ion gradients across neuronal cell membranes in the 
in the face of the continuous ionic fluxes during synaptic activity and action 
potential propagation. However, monitoring the distribution of glucose in the brain 
tissue has demonstrated that it is accumulated equally by neurons and stroglial 
cells. This implies the involvement of an intermediate product of glucose 
utilization, which is produced by astrocytes and subsequently transported to 
neurons. It turns out that astrocytes are ideally situated and have the biochemical 
machinery to provide metabolic support for neurons vio the so-called ‘astrocyte-
neuron lactate shuttle (Auld and Robitalle, 2003). 
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Figure 4: Schematic of the proposed mechanism of metabolic trafficking in the brain. Glucose 
from the vasculature is metabolized by astrocytes to lactate in the cytosol. Lactate is then 
exported into the extracellular fluid, and taken up by neurons, which utilize it via the TCA cycle. 
This first involves conversion (in the neuron's cytosol) of lactate to pyruvate, which is 
transported into the mitochondrion, and converted into acetyl-CoA, which then feeds into the 
TCA cycle. A portion of the TCA cycle intermediate α-ketoglutarate is converted into the spin-off 
product glutamate (From: Gallagher, 2009).  
Astroglia affect neuronal synaptic transmission in several ways. First, astrocytes 
modulate synaptic strength by controlling the concetration of neurotransmitters in 
the cleft via glial transporters. This is the case for most synapses that use amino 
acid neurotrnsmitters, such as glutamate, GABA and monoamines, where 
astrocytes exoress specific transporters, depending on the synapse. Second, ‘glio’ 
transmitters released from astrocytes also affect synaptic transmission in 
neighbouring neuronal circuits. And third astrocytes are also capable of modulating 
synaptic transmission through the release of ATP (Auld and Robitalle, 2003). 
Reactive astrogliosis 
One of the most important role of astrocytes is that they have a specific mechanism 
to protect the brain. Astrocytes respond to different forms of CNS insults including 
brain trauma, ischemia, infection or neurodegenerative disease by the process 
called reactive astrogliosis. reactive astrogliosis is a defensive brain reaction which 
is aimed at (a) isolation of the damaged area from the rest of the CNS tissue (b) 
reconstruction of the blood-brain barrier and (c) facilitation of the remodelling of 
brain circuits in areas surrounding the lesioned region. (Verkhratsky and Butt, 
2007). These main tasks are solved into two distinct ways: the reaction of 
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astrocytes close to the insult is very different from that in astroglial cells positioned 
at a distance from the primary lession.  
This reactive condition is divided into two stages (Fig. 5). During the first stage 
reactive astrocytes overexpress GFAP and become hypertrophic. Later, they 
release growth factors and cytokins (Verkhratsky and Butt, 2007; Sofroniew, 
2009). The second stage of astrogliosis occurs only under severe insults and 
includes the glial scar formation. The scar is formed from newly proliferating cells 
which origin is not known yet. The role of the scar is to form a border between the 
healthy and the damaged tissue (Fig. 5). 
Astrocytes located immediately around the damaged zone undergo a robust 
hypertrophy and proliferation, which ultimately ends up in complete substitution of 
previously existing tissue architecture with a permanent glia scar, this preocess is 
called anisomprphic astrogliosis. In astrocytes more distal to the lession, the 
reactive changes are much milder and although astroglial cells modify their 
appereance and undergo multiple biochemical and immunological changes, they do 
not distort the normal architecture of the CNS tissue, but rather permit growth of 
neurites and synaptogenesis, thus facilitating the remodelling of neuronal 
networks. This type of sdtrocyte reaction is defined as isomorphic astrogliosis 
(Verkhratsky and Butt, 2007). 
The primary signals, which trigger both forms of astrogliosis, derive from damaged 
cells in the vore of the insult, and are represented by neurotransmitters, cyokines 
and adhension molecules, growth factors and blood factors. The actual 
combination of these ‘damage signals’ and their relative concetrations most likely 
determine the type of astrogliosis experinced by astrocytes in different regions 
surrounding the initial zone (Verkhratsky and Butt, 2007). 
On a cellular level, insults to the brain, be they ischaemia, trauma or inflammation, 
result in hypertrophy of the astroglial processes and a signiicant increase on the 
astrocyte cytoskeleton. The biochemical hallmark of astrogliosis is the 
upregulation of synthesis of GFAP. In animals with genetically deleted GFAP the 
astroglial scar is formed slower, it is much less organized and the healing o brain 
traumas is generally prolonged (Penky, 2005). 
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Figure 5:  Stages of astrogliosis. First stage: innate factors that are relleased during brain 
insults trigger the activation of astrocytes, which become hypertrophic and proliferate 
intensively. Second stage: the damaged issue is replaced by a permanent glia scar. (From: 
Rechenbach  and Wolburg, 2005) 
(ILs: Interleukins, TGFβ: Transforming Growth Factor beta, NGF: Nerve Growth Factor, BBB: 
Blood Brain Barrier) 
Role of astrocytes in the nervous system pathology 
Because of the plethora of functions performed by astrocytes, particularly their 
protective role against brain insults, it is not surprising that these cells are involved 
in many diseases. On Table 1 are listed brain diseases in which astrocytes 
dysfunction is involved.  
Table 1: Diseases in which astrocytes dysfunction is involved. 
Brain diseases Astrocytes pathology Literature 
Alexander’s disease Astrocytes express 
mutated GFAP and 
develop Rosenthal fibres 




mutated NPC1 and cause 
neurodegeneration 
 
Alzheimer’s disease Astrocytes accumulate 
amyloid-β become 
Rodríguez et al., 2009 
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reactive and cause 
neuronal injury 
Parkinson 
Astrocytes are activated 
and attack neurons in 
psecific brain areas 
Sidoryk-Wegrzynowicz 
et al., 2011 
Amyotrophic lateral 
sclerosis (Lou Gehrig’s 
disease) 
Astrocytes loose their 
function in glutamate 
clearance and cause 
toxicity 
Seifert et al., 2006 
Schizophrenia Reduced number of 
astrocytes McKenzie et al., 2001 
Depression Spreading depression 
waves cause astrogliosis 
Verkhratsky and Butt, 
2007 
Stroke 
Astrocytes are unable to 
provide metabolic 
substrates to neurons 
Takano, 2009 
Gliomas Brain tumors developed by astroglia Sontheimer, 2003 
 
QKI- a new candidate gene for scizophrenia 
Schizophrenia is a neuropsychiatric disorder that affects 1% of the population 
worldwide (Aberg, 2005). Twin and adoption studies have shown that heritability 
of the disease is 80%. This indicates that both environmental and genetic factors 
are involved in the development of the disease. Environmental factors that are 
already proposed to be involved in schizophrenia affect the development of the 
brain. For example maternal infections during pregnancy have toxic effects on 
embryo’s neurons (Urakubo et al., 2001). Additionally, fetal hypoxic or ischemic 
damage that can be due to complications during pregnancy or delivery are also 
related to abnormal development of the CNS (Miyamoto et al., 2003 ). Although 
genetic factors are strongly involved in the etiology of Schizophrenia there is not a 
Mendelian inheritance as would be expected. The explanation for this is that more 
than one gene are responsible for the pathologic phenotype of the disease (Riley 
and McGuffin, 2000). 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 04:38:59 EET - 137.108.70.7
17 
 
Association, linkage and expression studies suggest that the quaking homolog KH 
domain RNA binding or QKI, is a novel candidate gene for schizophrenia 
(Lindholm et al, 2004 ). QKI belongs to the STAR protein family (Signal 
transduction and Activation of RNA). The members of this family regulate post-
transcriptionally the mRNA levels of various genes by directly binding to them in 
specific regions called QKI Response Element (QRE) (Galarneau and Richard, 
2005 ). In humans, QKI is expressed in 4 isoforms with different size (QKI-5, 
QKI-6, QKI-7, QKI-7b), which derive from alternative splicing of the same 
transcript. In the adult nervous system, QKI gene is exclusively expressed in glial 
cells. To date, the functional studies of QKI focused mainly on its role in 
oligodendrocytes, since white matter alterations have been associated with 
schizophrenia (Lindholm, 2004 ). These studies revealed that QKI is necessary and 
sufficient to promote oligodendrocyte differentiation and myelination (Chen et al., 
2007). Aberg et al. have found that the expression of QKI-7 and QKI-7b is 
downregulated in SCZ patients. It has been further proposed that abnormalities in 
alternative splicing of the gene may explain disrupted expression of several 
myelin-related genes observed in the patients (Aberg et al., 2006) 
Interestingly, QKI is also expressed in astrocytes and it has been shown that QKI-7 
specifically regulates the interferon related genes in human astrocytoma cells 
(Jiang, 2010 ). These results suggest that QKI has different function in 
oligodendrocytes and astrocytes. Further studies performed in this group revealed 
that QKI regulates expression of several structural and functional genes in human 
primary astrocytes (unpublished data). The physiological consequences of these 
QKI-driven expression changes in astrocytes are to be determined. 
However, it cannot be ruled out that alterations of astrocytic QKI may contribute to 
the phenotype observed in SCZ patients. In fact, the nature of cells with reduced 
QKI expression is not known. Furthermore, a role of astrocytes in schizophrenia 
has already been proposed (Jiang et al., 2010 ). 
Further studies are necessary to reveal the role of specific QKI splice variants in 
astrocytes. Since astrocytes are highly responsive to all types of brain insult, it is 
reasonable to investigate the role of QKI gene not only under normal physiological 
conditions, but also in the context of reactive astrogliosis that is a consequence of 
such insult.   
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The main purpose of this project was to develop an in vitro system that is suitable 
to study a specific function of QKI in human primary astrocytes under different 
physiological conditions. 1. We aimed to mimic astrocyte activation by treatment 
of human primary cells with thrombin and interpheron-γ (IFN-γ) – potent inducers 
of astrocyte activation in rodents. Additionally, we treated cells with haloperidol, 
an antipsychotic drug commonly used in the treatment of schizophrenia. 2. We 
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MATERIALS AND METHODS 
Cell cultures 
Primary human astrocytes (HA) (ScienCell) were cultivated in the astrocytes 
medium (ScienCell) supplemented with 2% fetal bovine serum (FBS), 1% 
Astrocyte Growth Supplement (AGS) and 1% penicillin/streptomycin (PS) 
(ScienCell). Cells (2nd passage HA) were plated onto poly-L-lysined (ScienCell) 75 
ml culture flasks (Costar). After reaching 80% confluence cells were removed 
from the flasks using trypsin and they were plated onto 6-well plates (Costar) at the 
density 5.000 cells/cm2. No antibiotics  were added to the medium after passaging. 
All cultures were maintained at 37oC and 5% CO2. 
 
Treatments 
We treated the cells with three different reagents: IFN-γ, thrombin and haloperidol. 
IFN-γ was obtained from PeproTech reconstituted with MiliQ water and further 
diluted into working solution with PBS containing 0.1% bovine serum albumin 
(BSA). Cells were treated with 10 ng/ml IFN-γ for 6h and 24h. Thrombin was 
obtained from Sigma and it was reconstituted with 0.1% BSA solution. Cells were 
treated with 1U/ml thrombin for 6h and 24h. Haloperidol (Sigma) was 
reconstituted in the plating medium to final concentration 0.2 µΜ, which is the 
same concentration detected in the blood plasma of treated patients. The duration 
of Haloperidol treatment was 6h and 24h. 
 
RNA extraction and real time RT-PCR 
RNA was isolated from the cells using the PureLink RNA MiniKit (Invitrogen) 
according to the manufacturer’s instructions. The concentration and purity of the 
extracted RNA was measured using NanoDrop ND1000 Spectophotometer. RNA 
integrity was monitored by agarose gel electrophoresis (two ribosomal bands 18S 
and 28S were intact in all samples). RNA samples were stored at -80oC until use 
for RT-PCR.  
 
From each biological replicate, 200 ng of RNA was reverse transcribed into cDNA 
using TaqMan Reverse Transcription Reagents (Applied Biosystems). The final 
concentrations of reagents were: 1x RT Buffer, 5.5 mM MgCl, 0.5 mM dNTPs 
(each), 2.5 µΜ random hexamers, 0.4 U/ml RNase inhibitor and 1.25 U/µl reverse 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 04:38:59 EET - 137.108.70.7
20 
 
transcriptase in RNAse free water to a final volume 10µl. The mix was incubated 
at 25oC for 10min. (primer annealing), 48oC for 1h (synthesis) and 95oC for 10min. 
(enzyme inactivation). cDNA samples were diluted with RNAse-free water to a 
final concentration 2.5 ng/µl and stored at -20oC. 
 
All real-time PCR experiments were performed in ABI Prism 7000 Sequence 
Detector System (Applied Biosystems) using 96-well optical plates (ABI). The 
reaction mix included 4 µl of cDNA sample, 9.5 µl of MiliQ water, 0,75 µl (10 
µΜ) of forward primer , 0,75µl (10 µM) of reverse primer and 10µl of Power 
SYBR ® Universal PCR Master Mix (ABI). Sequences of all primers are listed in 
Table 2. The thermal cycle was as follows: 50oC for 2min., 95oC for 1min., 40 
cycles of 95oC for 15sec. and 60oC for 1min. each. A dissociation step was added 
for each gene run. Gene expression was quantified using standard curve method 
and normalized against two housekeeping genes, GAPDH (Glyceraldehyde 3-
phosphate Dehydrogenase) and VIM (vimentin).  
 
 
Table 2: Genes and primers used in RT-PCR 
Gene 5’-Forward Primers-3’ 5’-Reverse Primer-3’ 
GAPDH GGAAGCTCACTGGCATGGC TAGACGGCAGGTCAGGTCCA 
B2M GTGCTCGCGCTACTCTCTCT TCTCTGCTGGATGACGTGAG 
VIM CGAAAACACCCTGCAATCTT ATTCCACTTTGCGTTCAAGG 
ACTB GAGCTACGAGCTGCCTGACG GTAGTTTCGTGGATGCCACAGGACT 
GFAP AAGAGGAACATCGTGGTGAAGAC CTGCCTCACATCACATCCTTGT 
GBP1 GCAGTTGCTAGAAAGAGCAAGAGA TCCCTCTTTTAGTAGTTGCTCCTGTT 
GLUL CACCTCAGCAAGTTCCCACT GAGCCATCGAAATTCCACTC 
QKI-T GCACCTACAGAGATGCCAACATTA CTGGGCTGTTGCTGCAAGA 




Human astrocytes were cultured on poly-L-lysined coverslips inserted into 6-well 
plates. Following treatment, cells were fixed in 4% paraformaldehyde (PFA) for 
15min. at room temperature. Each well was rinsed three times with PBS and then 
the blocking solution (0.25% Triton X-100, 0.25% BSA in PBS) was added for 1h. 
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Subsequently the cells were incubated with anti-GFAP chicken antibody (AbCam) 
diluted 1:1000 in blocking solution, and kept overnight at 4oC. After rinsing three 
times with PBS the secondary antibody Alexa647 goat-antichicken (Invitrogen) 
was applied (1:400) for 2h at room temperature. After rinsing with PBS the cells 
were stained with DAPI (Sigma). Finally the slides were mounted in DTG 
mounting solution. The slides were viewed and analyzed using Olympus 
microscope and images were finalized with the Image-J software. 
RNA silencing 
QKI gene was silenced in human primary astrocytes using stealth RNAi siRNA 
duplexes targeting all QKI splice variants (QKI-t) (Invitrogen). The sequence of 
the siRNA duplex was as follows: 5’-UAUAGAUUAAACCAGCUUCGGGCCC-
3’, 3’- AUAUCUAAUUUGGUCGAAGCCCGGG-5’. These siRNAs were 
targeting exon6 which is common for all QKI splice variants (Figure 3). As a 
control we transfected cells with scramble stealth RNAi siRNA (Invitrogen). All 
transfections were performed in biological duplicates using Lipofectamine 2000 
(Invitrogen), following manufacturer’s instructions. The final concentration of 
targeting and scramble siRNA in each well was 25 nM. 
In order to study whether QKI silencing may modify the response of human 
astrocytes to IFN-γ- activation, we treated QKI-silenced and scramble cells with 
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Figure 6: The structure of the quaking gene and the four isoforms in the human brain. Exon 
1-6 are common for all splice variants. siQKI-t is targeting exon 6 and suppress the expression 
of all QKI splice variants. (Modified from: Jiang, et al. 2010) 
 
Statistical analysis 
Statistical analysis was performed using two-tailed t-tests. The significance level is 
indicated with * p<0.05, **p<0.01, ***p<0.001 accordingly. Error bars indicate 
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Gene expression analysis of HA treated with thrombin. 
To test the effect of thrombin on astrocytes we treated primary human astrocytes 
with 1 U/ml thrombin and measured gene expression after 6h and 24h using real-
time PCR. After 6h of treatment only QKI-7 was affected and it was up-regulated 
although after 24h it showed a tendency for down-regulation. GFAP and GLUL 
have been significantly upregulated after 24h of treatment. All the other genes 
remained stable until the end of the treatment (Fig. 7). 
 
(A)                                                                                       (C) 
    
(B) 
 
Figure 7: Gene expression analysis of primary human astrocytes treated with 1u/ml Thrombin 
for (A) 6h and (B) 24h. The mRNA expression levels of thrombin treated cells are relative to 
untreated cells (Ctrl) which mRNA level is defined as 100. (C) Regression plot of normalization 
genes after the treatment with Thrombin. 
 
   * 
 ** 
 ** 
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Gene expression analysis of HA treated with Haloperidol 
Accordingly we treated primary human astrocytes with 0.2 µΜ of the antipsychotic 
drug Haloperidol and analyzed their gene expression. Gene analysis after 6h of 
treatment revealed an increase in the expression of GFAP and B2M and a tendency 
for increase in the expression of QKI-7 and GLUL. QKI-t, GBP1 and ACTB 
remained stable. After 24h the only significant change was the increase of GFAP. 
The rest of the tested genes were not affected by the treatment (Fig. 8). 
 (A)                                                                                       (C) 




Figure 8: Gene expression analysis of primary human astrocytes treated with 0.2 µΜ 
Haloperidol for (A) 6h and (B) 24h. The expression levels are expressed relative to untreated 
cells (Ctr) which mRNA level is defined as 100. (C) Regression plot of normalization genes after 






  * 
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Gene expression analysis of HA treated with IFN-γ 
We tested the effect of IFN-γ on human primary astrocytes. We treated primary 
cells with 10 ng/ml IFN-γ and analyzed gene expression with real-time PCR after 
6h and 24h. We observed an upregulation of the interferon-related genes GBP1 and 
B2M after 6h of treatment. These changes became even more pronounced after 24h 
of treatment. On the other hand QKI-7 and GFAP were down-regulated after 6h 
and 24h. (Fig. 9). 
(A)                                                                                        (C) 




Figure 9: Gene expression analysis of primary human astrocytes treated with 10 ng/ml IFN-γ 
for (A) 6h and (B) 24h. The expression levels are expressed relative to untreated cells (Ctr) 
which level is defined as 100. (C) Regression plots of genes which are used for normalization of 
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Changes in cell viability and morphology after treatment 
At the end of each treatment the cultures were studied with a phase-contrast 
microscope. Although initially all cultures were plated at the same density, cells 
treated with IFN-γ for 24 h seemed to be more dense compared to the untreated 
cultures. The density of cultures that were treated with thrombin or haloperidol was 
similar to the control. The higher density of the IFN-γ treated cells suggests that 
IFN-γ may induce cell proliferation rate (Fig. 10) 
    
Figure 10: Phase contrast images of human astrocytes treated with different reagents for 24h. 
(A) Control culture of human astrocytes (B) Human astrocytes treated with 0.2 µΜ Haloperidol 
(C) Human astrocytes treated with 10 ng/ml IFN-γ (D) Human astrocytes treated with 1 U/ml 
thrombin. Scale bar 20µm. 
In order to examine morphological differences between the treated and control 
cells we performed immunocytochemical staining using antibodies against GFAP, 
a cytoskeleton protein commonly used as a specific marker for astrocytes. A 
control culture of primary human astrocytes was morphologically heterogeneous. 
After the treatment with IFN-γ the cell’s morphology changed substantially and 
many longitudinal cells with thin long processes were observed. We also noticed 
that fewer processes were formed ( Fig 11). On the other hand, the cells treated 
with thrombin or haloperidol seemed larger and had thicker processes. Furthermore 
these cells developed higher diameter processes (Fig. 11). 
 
 
A B C D 
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Figure 11:  Changes in GFAP expression have an afect on astrocytes’ morphology. 
Immunocytochemical staining of GFAP in astrocytes treated with three different reagents for 
24h. The diagramms show changes in GFAP  expression according to each treatment. The 
pictures were taken at 40x magnification. 
 
Silencing the expression of QKI-t in HA treated with IFN-γ 
In order to study the function of QKI in activated astrocytes we tested how primary 
human astrocytes react to stimulation with IFN-γ when QKI is not expressed. First 
we silenced the expression of the QKI gene using small interference RNA 
complementary to the QKI-t transcript and then we treated the cells with 10 ng/ml 
IFN-γ for 48h. After the treatment we analyzed the genes expression and the 
morpgological changes of the cells. At the end we had four groups of cells: Scram 
– transfected with scramble siRNA, untreated; siQKI-Tot – transfected with siRNA 
targeting QKI-t, untreated; Scram IFN-γ – transfected with scramble siRNA, 
treated with IFN-γ; siQKI-Tot IFN-γ - transfected with siRNA targeting QKI-t and 
treated with IFN-γ.  
The expression levels of QKI-t after 48h of transfection was at 50% of control 
level ( Fig. 11) Other genes that were down-regulated after the transfection were 
GFAP, B2M and GLUL. In contrast, GBP1 was up-regulated and ACTB was 
stable. 
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The treatment with IFN-γ for 48h had an effect on gene expression as in the 
previous experiment. Briefly, GBP1 and B2M were overexpressed, QKI-7 and 
GFAP were decreased and QKI-t and ACTB were not affected. We next measured 
gene expression in  the cells that were both transfected with siQKI-Tot and treated 
with IFN-γ we observe that the down-regulated genes after the IFN treatment 
(Scram IFN-γ) had recover. QKI-7 and GFAP were almost in control levels and 
ACTB and GLUL were slightly increased. On the other hand the interferon related 
genes remained highly expressed even after the transfection. 
Phase contrast images also revealed that IFN-γ caused morphological changes in 
astrocytes that are not affected by the silencing. After the IFN-γ treatment the cells 
developed long and thin processes (black arrows in Fig. 13) 
 
              
Figure 12: Gene expression analysis of primary human astrocytes transfected with siRNA 
targeting QKI-t and treated with 10 ng/ml IFN-γ for 48h. The diagram depicts the mRNA levels 
of untreated cells (Scram), cells treated with IFN-γ (Scram IFN-γ), cells transfected with QKI-
Tot siRNA (siQKI-t) and cells transfected with QKI-Tot siRNA and treated with IFN-γ (siQKI-t 
IFN-γ. Error bars indicate the standard error of the mean for four replicates (two biological 
duplicates, two technical duplicates 
.        
Institutional Repository - Library & Information Centre - University of Thessaly




Figure 13: Phase contrast images of human astrocytes  transfected with siQKI-Tot and treated 
with 10 ng/ml IFN-γ for 48h. The black arrows in the treated cells indicate the longitudinal 
processes that are develped after the treatment. Scale bar 20µm. 
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We treated primary human astrocytes with two reagents that are known from 
literature to trigger astrogliosis in the brain after treatment (Niego et al., 2011; John 
et al., 2003). We also treated astrocytes with an antipsychotic drug, which affects 
astrocytes (Jiang et al., 2009 ). We measured the expression of specific astrocytic 
markers, cytoskeleton genes and genes that are involved in immunological 
respond. It is already known that the expression of these three groups of genes is 
modified during astrogliosis (Verkhratsky and Butt, 2007). We also measured the 
expression of QKI-t and its splice variant QKI-7 in order to study if the expression 
of this gene changes under conditions that cause astrogliosis. Each treatment 
affected the astrocytes differently and changed the mRNA levels of the studied 
genes into different directions. 
Thrombin is a trypsin-like serine protease which is known for its role in 
coagulation pathway. However, thrombin can also penetrate into the brain through 
the blood-brain barrier after hemorrhage or be produced directly in the brain during 
cerebral ischemia (Niego et al., 2011). It was found that thrombin in the brain 
causes changes in the morphology and in proliferation rate of astrocytes, the same 
as in activated cells (Shirakawa et al., 2010; Ubl and Reiser, 1997). We used 
primary cultures of human astrocytes which we treated with thrombin and we 
observed changes in the morphology and genes’ expression. GFAP is a 
cytoskeleton protein and one of the hallmarks for astrogliosis and it was up-
regulated after the treatment with thrombin. Furthermore, the up-regulation of 
GFAP caused morphological changes in the cells such as hypertrophy. 
Additionally, we saw an effect in the expression of GLUL which is a specific 
astrocytic marker. GLUL is responsible for the conversion of glutamate to 
glutamine, which in turns is shuttled to neurons when it serves as substrate for 
glutamate production. We also detect an up-regulation in QKI-7 expression which 
in contrast to the other affected genes was transient. 
Our results reflect three basic characteristics of activated astrocytes which indicate 
that primary human astrocytes respond to thrombin accordingly to previous studies 
in rats’ astrocytes (Suidan, 1997; Niego, 2011). Furthermore an effect of thrombin 
in QKI expression reveals that this gene has a function in reactive astrocytes. The 
fact that the increase of QKI-7 was preceded and that QKI is a member of the 
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STAR family indicates that QKI is involved in the beginning of astrogliosis by 
regulating the expression of other involved genes.  
Haloperidol is a typical antipsychotic drug which is widely used among 
schizophrenic patients (Joy et al., 2001) and it was shown that one of its in vitro 
effects was to increase the expression of QKI in cells from patients’ brain (Aberg 
et al., 2006 ). Further studies in human astrocytoma cells revealed that astrocytes 
are target cells for haloperidol which can cause overexpression of QKI-7 (Jiang, 
2009 ). In this study we repeated the experiment of Jiang et al using primary 
human astrocytes and we observed a strong tendency for increase in the expression 
of QKI-7 after 6h of treatment which is in accordance with the previous results. 
Additionally we measured the expression of more genes and we detect that GFAP 
and B2M are also up-regulated although B2M is again in control levels after 24h. 
Subsequently, GFAP overexpression had an effect on the morphology of astrocytes 
which become hypertrophic and develop more processes than control cells.  
These results indicate that haloperidol may activate astrocytes in a similar way 
with innate factors that cause astrogliosis. It was already known that QKI responds 
to haloperidol but now we can associate the overexpression of QKI with the 
activated astrocytes. Transient increase of QKI may play a role in the first stage of 
astrogliosis and its expression is not necessary in further activation. Further studies 
may reveal the relationship between haloperidol and astrogliosis. 
Finally we studied the effect of IFN-γ in human astrocytes. IFN-γ is an 
inflammatory cytokine and is mainly produced by systematic lymphocytes such as 
T-cells and natural killer cells (John et al., 2003 ). It is involved in many different 
cellular programs such as antiviral, antibacterial and anti-tumor protection 
(Aschner, 1998 ). Recently it was proposed that IFN-γ is also involved in 
neuroinflammatory processes by stimulating glial cells to produce adhesion 
molecules, express MHC class I and II and secrete other proinflammatory 
cytokines (Dong and Benveniste, 2001 ). On the other hand genes that are 
stimulated by cytokines were up-regulated in schizophrenia brains supporting an 
inflammatory hypothesis of the disease (Saetre et al., 2007). Since astrocytes are 
one of the immunocompetant cell-type in the brain they may be involved in this 
new hypothesis. We observed that astrocytes respond to IFN treatment with a 
dramatic overexpression of GBP1 and B2M which both are interferon-induced 
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genes. Additionally, we detected a significant down-regulation of GFAP which 
caused morphological changes in the cells. After the interferon treatment the cells 
lost completely their star-like shape, they were longitudinal and developed a few 
thin processes. Furthermore, by comparing cell density after 24h between control 
and treated cultures we observed that IFN may affect the proliferation rate of 
astrocytes, however, this observation should be verified by a viability test. 
The fact that the genes expression pattern of the cells is modified and inflammation 
related genes, which normally are not expressed, are expressed after the treatment, 
and that the proliferation rate of the cells is probably increased indicates that IFN-γ 
stimulates astrocytes. However, GFAP is decreased and astrocytes are 
hypertrophic, thus astrocytes are activated after the IFN treatment in a way 
different of astrogliosis. Astrocytic activation by cytokines has already been 
described in mice-models and it was proposed that such activation reflects the 
brains’ response to infections (John et al., 2003 ).  
Another characteristic of cytokine-activated astrocytes was that the expression of 
QKI-7 was decreased, indicating that the mechanism of this activation affects QKI. 
In order to study the function of QKI under this condition we combined the 
silencing of QKI with IFN treatment for 48h. As control we had cells in which we 
silenced QKI-t and cells which were treated with IFN-γ for 48h. These two 
cultures certified that QKI-t and QKI-7 expression was decreased after the 
transfection with the siRNA and that astrocytes have the same genes’ expression 
pattern after 48h of treatment like after 24h, thus they were activated. Additionally 
we detected that when QKI was not expressed GFAP and B2M were down-
regulated. According to literature we expected that these genes would be decreased 
but we also expected the same decrease for GBP1 (Jiang et al., 2010 ). It is 
possible that we did not observe any change in GBP1 expression because the 
expression of QKI was decreased at 50% and not more than 80% like previous 
studies. When we silenced the expression of QKI-t and subsequently treated the 
cells with IFN-γ we observed that the interferon related genes were still 
overexpressed but with a slight decrease and that QKI-7 and GFAP were expressed 
in control levels. 
IFN-γ causes to astrocytes a reactive condition in which they could act like 
immune cells and in which the expression of QKI-7 and GFAP are low. However 
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QKI-7 is involved in the mechanism of this condition because IFN-γ recovers its 
expression after silence. These results are in agreement with previous studies 
which have shown that QKI-7 specifically regulates the expression of the 
interferon-related genes (Jiang et al., 2010 ). Thus, QKI-7 should be expressed 
during activation by cytokines because it may regulate the expression of the 
interferon-related genes which is essential for this condition.  
However when QKI is silenced the effect of IFN-γ on astrocytes is lighter while 
IFN-γ causes also an increase in the expression of QKI-7 and GFAP. These results 
agree with previous studies which have shown that QKI-7 regulates the expression 
of GFAP and interferon-related genes. Furthermore these results indicate that QKI 
is eventually involved in the cytokine-activation of astrocytes.  
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Gene analysis and observation of the cell cultures indicate that factors which cause 
activation of astrocytes in the brain have the same effect when they are used in 
vitro. Thrombin and the antipsychotic drug haloperidol stimulate astrocytes and 
cause astrogliosis while IFN-γ affects them differently and causes immunologic 
activation. The in vitro activation of astrocytes mimic pathological conditions of 
the brain and offers cells that can be used for further studies of these conditions. It 
was common to our results that modifications in genes’ expression did not reach 
the significance level probably because of the high standard error. A solution to 
this problem would be the repetition of the experiments with more biological 
replicates. Hence future research which will include more tests on cells and 
optimization of the variable parameters is needed in order to establish a fully 
reliable model of activated astrocytes. 
From our analysis was shown that QKI is involved in both kinds of activation. We 
tested only the significance of QKI under the immunologic activation but it would 
be also interesting to study the relationship of QKI and astrogliosis in the future. 
When astrocytes are activated by IFN-γ QKI-7 is decreased indicating that its 
expression is not essential. However when the expression of QKI is modified IFN-
γ reset the expression of QKI-7 in normal levels. Thus when the expression of QKI 
is disturbed IFN-γ is able to increase the expression of QKI-7 at the level which is 
essential for the immunologic activation of astrocytes. This observation was after 
48h of treatment and does not show how the expression levels of QKI-7 are 
changing during the treatment. Time course observation could reveal if IFN-γ 
triggers the expression of QKI-7 directly or through other mediators. Future studies 
in the relationship between QKI and IFNs will be useful in the research of etiology 
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